title: [Clinical and laboratory features of aseptic meningitis associated with measles-mumps-rubella vaccine].
abstract: OBJECTIVE
  To describe epidemiological, clinical, and cerebrospinal fluid (CSF) findings in cases of aseptic meningitis associated with measles-mumps-rubella vaccination following a mass immunization campaign in the Brazilian state of Bahia in August 1997 promoted by the country's Ministry of Health, and to compare these cases to the cases of aseptic meningitis not associated with the vaccine that occurred in the same year.
  
  
  METHODS
  Between March 1997 and October 1997, all individuals between 1 and 12 years of age admitted to the Couto Maia Hospital (the Bahia reference hospital for infectious illnesses) with a clinical and laboratory diagnosis of aseptic meningitis were prospectively followed. The study population was divided into two groups: one with individuals who had received the vaccine, and one with individuals who had not received the vaccine. Demographic, clinical, and laboratory information was collected on both groups.
  
  
  RESULTS
  In September, following the vaccination campaign, 74 cases of aseptic meningitis were registered at the Couto Maia Hospital, versus the monthly average of 7.5 cases. We observed a greater frequency of nuchal rigidity and increased CSF cellularity among children whose meningitis was associated with the vaccine. However, encephalitic involvement was more frequent in the group of children with non-vaccinal meningitis.
  
  
  CONCLUSIONS
  Although the course of post-vaccinal meningitis is more benign than that of other forms of the disease, its treatment generates costs related to ancillary exams and hospitalizations. Mass vaccination campaigns should employ less reactogenic vaccine strains.
authors.affiliation: Bolsista do Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Salvador, BA, Brasil.
authors.forename: Rita
authors.initials: R
authors.lastname: Lucena
authors.forename: Irenio
authors.initials: I
authors.lastname: Gomes
authors.forename: Luciana
authors.initials: L
authors.lastname: Nunes
authors.forename: Sérgio
authors.initials: S
authors.lastname: Cunha
authors.forename: Inês
authors.initials: I
authors.lastname: Dourado
authors.forename: Maria Da Glória
authors.initials: Mda G
authors.lastname: Teixeira
authors.forename: Julieta
authors.initials: J
authors.lastname: Goes
authors.forename: Eduardo
authors.initials: E
authors.lastname: Cardoso
authors.forename: Bernardo
authors.initials: B
authors.lastname: Rodrigues
authors.forename: Adriana
authors.initials: A
authors.lastname: Cardoso
authors.forename: Maurício L
authors.initials: ML
authors.lastname: Barreto
authors.forename: Ailton
authors.initials: A
authors.lastname: Melo
mesh_terms: D002648:Child; D005260:Female; D006801:Humans; D008297:Male; D022542:Measles-Mumps-Rubella Vaccine / Q000009:adverse effects*; D008581:Meningitis / Q000134:cerebrospinal fluid* / Q000453:epidemiology / Q000209:etiology*; D011446:Prospective Studies
chemical_list: D022542:Measles-Mumps-Rubella Vaccine